Programma
| Thursday - October 1, 2020 | |
| dalle 14.00 | Accesso partecipanti |
| 14.15-14.30 | Meeting Introduction and Authority Salutations Sergio Bracarda |
| 14.30-15.00 | Prostate Lecture
Towards a Genomic Address in Prostate Cancer Landscape Johann De Bono |
| mHSPC: Which Patients present with Advanced Disease and What We have to Do? MODERATORI: Enrico Cortesi, Rodolfo Montironi |
|
| 15.00-15.15 | NGP (Next Generation Pathology): Which Data? Alessia Cimadamore |
| 15.15-15.30 | NGI (Next Generation Imaging) Suggestions Stefano Fanti/ Andrea Farolfi |
| 15.30-15.45 | NGT (Next Generation Treatments). Available Trial’ Data Alberto Dalla Volta |
| 15.45-16.00 | NGS (Next Generation Sequencing): Where are We going? Vincenza Conteduca |
| 16.00-16.45 | Open Discussion |
| Prostate Cancer “Melting Pot” Debate (AS, MØ CRPC, Sequencing Options, ..): Who treat, When and How ? MODERATORI: Vittorio Donato, Giuseppe Procopio |
|
| 16.45-17.00 | NGP (Next Generation Pathology): Identifying Pathological predictor of aggressiveness for MØ CRPC Candidates to “Active Surveillance” or “Active Treatment Matteo Brunelli |
| 17.00-17.15 | NGT (Next Generation Treatments): which 2nd Line CRPC Treatment selection between ARTAs and Docetaxel? Reflecting on the available prospective sequencing Data (CARD) Orazio Caffo |
| 17.15-17.30 | NGT (Next Generation Treatments): PARP Inhibitors and Immuno-Oncology options in advanced Prostate Cancer, a Niche or more? Michele Milella |
| 17.30 – 18.00 | Open Discussion |
| Friday - October 2, 2020 | |
|
Urothelial Cancers: Towards a New Scenario MODERATORI: Francesco Massari, Claudia Mosillo |
|
| 14.00 – 14.15 |
NGP (Next Generation Pathology): Looking for innovative Urothelial Cancer Classifications considering eventual Druggable Targets Carlo Patriarca |
| 14.15 – 14.30 |
NGT (Next Generation Treatment): Where are We going in first line? Claudia Caserta |
| 14.30 – 14.45 |
NGT (Next Generation Treatment): which available and awaited data for the 2nd Lines in Advanced Disease? Patrizia Giannatempo |
| 14.45 – 15.00 | Open Discussion |
| 15.00 – 15.30 |
Urothelial Cancers Lecture
What next for urothelial Cancers? Tom Powles |
|
Kidney Cancer Debate: Treatment Choice by Line and Prognostic Factors? MODERATORI: Annalisa Guida, Roberto Sabbatini |
|
| 15.30 – 15.45 |
NGP (Next Generation Pathology): what’s about Innovative Histological details also considering eventual Druggable Targets Guido Martignoni |
| 15.45 – 16.00 |
NGT (Next Generation Treatment): Optimal candidates to different Approaches in the 1st Line Setting Camillo Porta |
| 16.00 - 16.15 |
NGT (Next Generation Treatment): Which possible Options in the “new Following Lines” Scenario? Roberto Iacovelli |
| 16.15 – 16.30 | Open Discussion & Round Table |
| Advanced Kidney Cancer Lecture | |
| 16.30-17.00 |
May We speak of a possibility of a Cure? Laurence Albiges |
| 17.00-17.30 | Critical Synthesis with Prize for the Best 2020 Communication in GU Oncology and salutation to the 9th WTC-GU 2021 Edition |
| 17.30-18.00 | Closing Remarks and Take home message |
